Clinical Trials

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT03387553 2026-03-27

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Phase 3 Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT02089100 2026-03-19

STEREO-SEIN

154 enrolled

Breast Neoplasms

NCT03978663 2026-02-20

TRIO

40 enrolled

Phase 1/2 Not yet recruiting

High-Risk Cancer

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07407244 2026-02-17

AKRA

268 enrolled

Breast Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

180 enrolled

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

111 enrolled

Breast Neoplasms

NCT06498154 2025-12-19

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

200 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast Neoplasms

NCT00462696 2025-10-06

ISNA-Sein

Phase NA Completed

16 enrolled 2 charts

Breast Neoplasms

NCT00872625 2025-09-30

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Phase 1 Completed

26 enrolled

Breast Neoplasms

NCT06611813 2025-08-12

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

30 enrolled

Breast Neoplasms

NCT06874933 2025-08-12

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

35 enrolled

Breast Neoplasms

NCT06876636 2025-07-29

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

99 enrolled

Breast Cancer Metastatic

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

27 enrolled

Breast Neoplasms

NCT06977893 2025-05-18

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

Phase 3 Recruiting

194 enrolled

Breast Neoplasms

NCT06190600 2025-04-30

SPORTNATHy

40 enrolled

Breast Neoplasms, Motor Activity

NCT05296746 2025-03-18

RIBOLARIS

1,100 enrolled

Breast Neoplasms

NCT05992870 2025-03-17

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

40 enrolled

Breast Neoplasms

NCT01781338 2025-02-27

ADAPT

Phase 2/3 Completed

4,936 enrolled

Breast Neoplasms

NCT06832904 2025-02-18

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

33 enrolled

HER2-positive Breast Cancer

NCT06793553 2025-01-30

INDUCE

106 enrolled

Breast Neoplasms

NCT06642428 2025-01-17

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

140 enrolled

Phase 2/3 Not yet recruiting

Breast Neoplasms

NCT06769919 2025-01-10

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

340 enrolled

Breast Neoplasms

NCT06631066 2024-10-08

Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients

Phase NA Completed

160 enrolled

Phase 2 Not yet recruiting

Breast Cancer Female

NCT06435104 2024-07-09

Aromatherapy in the Treatment of Early Breast Cancer

30 enrolled

Anxiety Disorders, Breast Neoplasms

NCT05216900 2024-06-21

BRENAR

20 enrolled

Breast Neoplasms

NCT06313073 2024-03-15

Neoadjuvant Radiotherapy for Breast Cancer

Phase NA Unknown

60 enrolled

Breast Neoplasms

NCT02956473 2024-03-12

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Phase NA Completed

57 enrolled 10 charts

Breast Neoplasms

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

4 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT06080620 2023-10-12

The Choice of Treatment Methods and Efficacy of LABC

50 enrolled

Locally Advanced Breast Cancer

NCT00499083 2023-09-29

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

17 enrolled 5 charts

Breast Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast Neoplasms

NCT00881361 2023-04-27

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

756 enrolled 12 charts

Breast Neoplasms

NCT01147016 2023-04-27

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

Phase 2 Terminated

8 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT03121989 2023-03-30

LABC

Phase 1 Withdrawn

Breast Neoplasms

NCT05479409 2022-07-29

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Phase 2 Unknown

50 enrolled

Breast Neoplasms

NCT03417622 2021-02-25

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3 Recruiting

370 enrolled

Margins of Excision, Breast Neoplasms

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00290745 2020-12-04

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Phase 1/2 Completed

79 enrolled 15 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

21 enrolled

BreastGastrointestinalHead & Neck

Breast Neoplasms

NCT03323424 2020-01-30

IRAM

Phase 2 Withdrawn

Breast Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01099436 2020-01-21

NEO-ZOTAC

Phase 3 Completed

250 enrolled

Breast Neoplasms

NCT03520894 2019-10-22

ROCK

Phase NA Unknown

25 enrolled

Breast Neoplasms

NCT01367288 2019-05-28

NEOZOL

53 enrolled

Breast Neoplasms, Neovascularization, Pathologic

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Phase NA Terminated

44 enrolled 3 charts